---
title: "Telo Genomics files US provisional patent for TeloView liquid biopsy MRD algorithm in multiple myeloma"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/292188448.md"
description: "Telo Genomics filed a U.S. provisional patent for its TeloView liquid biopsy MRD algorithm targeting multiple myeloma. The application focuses on relapse-risk prediction and isolating circulating cancer cells from peripheral blood, offering a potential alternative to invasive bone marrow testing. This move expands the company's IP position in blood-based MRD monitoring, supported by validation work with the University of Athens."
datetime: "2026-07-09T11:02:12.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/292188448.md)
  - [en](https://longbridge.com/en/news/292188448.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/292188448.md)
generator: "portal-rs"
---

# Telo Genomics files US provisional patent for TeloView liquid biopsy MRD algorithm in multiple myeloma

-   Telo Genomics filed a U.S. provisional patent application for a new TeloView biomarker algorithm for liquid biopsy MRD use in multiple myeloma. \* Application targets relapse-risk prediction in MRD settings, including a workflow to isolate circulating cancer cells from peripheral blood. \* Move expands the company’s IP position in blood-based MRD monitoring, a potential alternative to invasive bone marrow testing. \* Validation work includes a University of Athens collaboration using a large liquid-biopsy cohort with EuroFlow results for comparison. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Telo Genomics Corp. published the original content used to generate this news brief via Newsfile (Ref. ID: 202607090700NEWSFILECNPR\_\_\_\_20260709\_304547\_1) on July 09, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)

### Related Stocks

- [TELO.US](https://longbridge.com/en/quote/TELO.US.md)

## Related News & Research

- [Burning Rock CanCatch Custom MRD kit enters NMPA innovative device special review procedure](https://longbridge.com/en/news/296933190.md)
- [Adaptive Biotechnologies (ADPT), Why Is It Getting Fresh Attention Now?](https://longbridge.com/en/news/297264786.md)
- [Bluesky adds an ‘algorithmic opt-out’ feature for those who don’t want to go viral](https://longbridge.com/en/news/297228368.md)
- [Natera and Susan G. Komen® Announce National Partnership to Accelerate Progress Against Breast Cancer | NTRA Stock News](https://longbridge.com/en/news/297346091.md)
- [Imunon to host R&D day spotlighting Phase 3 OVATION 3 trial for IMNN-001 in ovarian cancer](https://longbridge.com/en/news/297045598.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**